Cash and Cash Equivalents, at Carrying Value of NovelStem International Corp. from 30 Jun 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
NovelStem International Corp. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Jun 2010 to 30 Jun 2025.
  • NovelStem International Corp. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Jun 2025 was $1,106.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

NovelStem International Corp. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,106* -$6,765 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $3,401,000 +$3,395,819 31 Mar 2025 10-Q 19 May 2025 2025 Q1
Q4 2024 $6,099* -$46,964 31 Dec 2024 10-Q 06 Aug 2025 2025 Q2
Q3 2024 $45,319 +$38,356 +551% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $7,871 -$26,454 -77% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,181* -$35,381 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $53,063 +$46,717 31 Dec 2023 10-K 07 Apr 2025 2024 FY
Q3 2023 $6,963 -$9,929 -59% 30 Sep 2023 10-Q 17 Nov 2023 2023 Q3
Q2 2023 $34,325 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $40,562 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $6,346* -$2,320 31 Dec 2022 10-Q 17 Nov 2023 2023 Q3
Q3 2022 $16,892 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q4 2021 $8,666 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2013 $24,867,007 +$18,907,206 +317% 30 Sep 2013 10-Q 29 Oct 2013 2013 Q3
Q2 2013 $9,669,277 +$7,260,805 +301% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 $9,946,831 +$6,608,702 +198% 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 $11,378,519 +$7,695,456 +209% 31 Dec 2012 10-Q 29 Oct 2013 2013 Q3
Q3 2012 $5,959,801 +$420,852 +7.6% 30 Sep 2012 10-Q 29 Oct 2013 2013 Q3
Q2 2012 $2,408,472 -$2,120,792 -47% 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 $3,338,129 -$2,255,353 -40% 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 $3,683,063 -$25,689,254 -87% 31 Dec 2011 10-Q 29 Oct 2013 2013 Q3
Q3 2011 $5,538,949 +$1,791,823 +48% 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3
Q2 2011 $4,529,264 +$73,991 +1.7% 30 Jun 2011 10-Q/A 12 Sep 2012 2012 Q2
Q1 2011 $5,593,482 31 Mar 2011 10-Q 15 May 2012 2012 Q1
Q4 2010 $29,372,317 31 Dec 2010 10-K 01 Apr 2013 2012 FY
Q3 2010 $3,747,126 30 Sep 2010 10-Q 21 Nov 2011 2011 Q3
Q2 2010 $4,455,273 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.